BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 32144513)

  • 1. Burkitt and Burkitt-Like Lymphomas: a Systematic Review.
    Saleh K; Michot JM; Camara-Clayette V; Vassetsky Y; Ribrag V
    Curr Oncol Rep; 2020 Mar; 22(4):33. PubMed ID: 32144513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
    Fujishima N; Fujishima M; Inomata M; Yamanaka Y; Saitoh K; Kameoka Y; Yoshioka T; Saitoh H; Takahashi N; Hirokawa M; Sawada K
    Rinsho Ketsueki; 2007 Apr; 48(4):326-31. PubMed ID: 17515125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in the management of Burkitt's lymphoma.
    Levine AM
    Clin Lymphoma; 2002 Dec; 3 Suppl 1():S19-25. PubMed ID: 12521385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt lymphoma- a rare but challenging lymphoma.
    Casulo C; Friedberg JW
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):279-284. PubMed ID: 30213397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.
    Liu D; Shimonov J; Primanneni S; Lai Y; Ahmed T; Seiter K
    Mol Cancer; 2007 Jun; 6():35. PubMed ID: 17547754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome abnormalities may correlate with prognosis in Burkitt/Burkitt-like lymphomas of children and adolescents: a report from Children's Cancer Group Study CCG-E08.
    Lones MA; Sanger WG; Le Beau MM; Heerema NA; Sposto R; Perkins SL; Buckley J; Kadin ME; Kjeldsberg CR; Meadows A; Siegel S; Finlay J; Bergeron S; Cairo MS;
    J Pediatr Hematol Oncol; 2004 Mar; 26(3):169-78. PubMed ID: 15125609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of two cases of Burkitt lymphoma/leukemia with concurrent t(8;14) and t(14;18)].
    Wang Z; Lai YY; Feng L; Liu YR; Qin YZ; Wang YZ; Shi HX; Jiang Q; Lu J; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):93-6. PubMed ID: 22391173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric precursor B-cell acute lymphoblastic leukemia with MYC 8q24 translocation - how to treat?
    Zhang C; Amos Burke GA
    Leuk Lymphoma; 2018 Aug; 59(8):1807-1813. PubMed ID: 29022749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burkitt's acute lymphocytic leukemia (L3ALL) in adults.
    Fenaux P; Bourhis JH; Ribrag V
    Hematol Oncol Clin North Am; 2001 Feb; 15(1):37-50. PubMed ID: 11253608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
    Oosten LEM; Chamuleau MED; Thielen FW; de Wreede LC; Siemes C; Doorduijn JK; Smeekes OS; Kersten MJ; Hardi L; Baars JW; Demandt AMP; Stevens WBC; Nijland M; van Imhoff GW; Brouwer R; Uyl-de Groot CA; Kluin PM; de Jong D; Veelken H
    Ann Hematol; 2018 Feb; 97(2):255-266. PubMed ID: 29209924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of translocation t(8;14)(q24;132) in pediatric Burkitt's lymphomas using "long distance" polymerase chain reaction: a new method for diagnosis of Burkitt's lymphomas].
    zur Stadt U; Reiter A; Welte K; Sykora KW
    Klin Padiatr; 1997; 209(4):165-71. PubMed ID: 9340426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.
    Sun H; Savage KJ; Karsan A; Slack GW; Gascoyne RD; Toze CL; Sehn LH; Abou Mourad Y; Barnett MJ; Broady RC; Connors JM; Forrest DL; Gerrie AS; Hogge DE; Narayanan S; Nevill TJ; Nantel SH; Power MM; Sutherland HJ; Villa D; Shepherd JD; Song KW
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):341-8. PubMed ID: 25656914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo acute B cell leukemia/lymphoma with t(14;18).
    Stamatoullas A; Buchonnet G; Lepretre S; Lenain P; Lenormand B; Duval C; Callat MP; Gaulard P; Bastard C; Tilly H
    Leukemia; 2000 Nov; 14(11):1960-6. PubMed ID: 11069032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.
    Alwan F; He A; Montoto S; Kassam S; Mee M; Burns F; Edwards S; Wilson A; Tenant-Flowers M; Marcus R; Ardeshna KM; Bower M; Cwynarski K
    AIDS; 2015 May; 29(8):903-10. PubMed ID: 25730506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
    Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
    Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
    Jost LM; Jacky E; Dommann-Scherrer C; Honegger HP; Maurer R; Sauter C; Stahel RA
    Ann Oncol; 1995 May; 6(5):445-51. PubMed ID: 7545428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.
    Barnes JA; Lacasce AS; Feng Y; Toomey CE; Neuberg D; Michaelson JS; Hochberg EP; Abramson JS
    Ann Oncol; 2011 Aug; 22(8):1859-64. PubMed ID: 21339382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
    Ayers EC; Li S; Medeiros LJ; Bond DA; Maddocks KJ; Torka P; Mier Hicks A; Curry M; Wagner-Johnston ND; Karmali R; Behdad A; Fakhri B; Kahl BS; Churnetski MC; Cohen JB; Reddy NM; Modi D; Ramchandren R; Howlett C; Leslie LA; Cytryn S; Diefenbach CS; Faramand R; Chavez JC; Olszewski AJ; Liu Y; Barta SK; Mukhija D; Hill BT; Ma H; Amengual JE; Nathan S; Assouline SE; Orellana-Noia VM; Portell CA; Chandar A; David KA; Giri A; Hess BT; Landsburg DJ
    Cancer; 2020 Jan; 126(2):293-303. PubMed ID: 31568564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.